FDA May Revise Import Notices; Bills Would Jeopardize Safety, Agency Says
Executive Summary
FDA is considering changes to its import warning notice procedures, the agency said in a July 25 letter to Commerce Committee Ranking Democrat Dingell (Mich.).
You may also be interested in...
Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws
Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.
Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws
Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.
Senate Re-Importation Bill Opposed By Wholesalers, Chains; NCPA Supports
The record-keeping provisions in Sen. Jeffords' (R-Vt.) pharmaceutical importation amendment are drawing opposition from the large wholesaler and chain drug trade associations.